Simeon George's Net Worth

$781 Million

Estimate Recalculated May 3, 2024 04:53PM EST

Who is Simeon George?

Simeon George has an estimated net worth of $781 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Principia Biopharma Inc., Arcellx, Inc., Design Therapeutics, Inc., Nkarta, Inc., CRISPR Therapeutics AG, GENOCEA BIOSCIENCES, INC., eFFECTOR Therapeutics, Inc., and HTG MOLECULAR DIAGNOSTICS, INC.

SEC CIK

Simeon George's CIK is 0001595117

Past Insider Trading and Trends

2022 was Simeon George's most active year for acquiring shares with 15 total transactions. Simeon George's most active month to acquire stocks was the month of May. 2022 was Simeon George's most active year for disposing of shares, totalling 9 transactions. Simeon George's most active month to dispose stocks was the month of August. 2022 saw Simeon George paying a total of $52,574,078.00 for 7,776,340 shares, this is the most they've acquired in one year. In 2020 Simeon George cashed out on 3,052,433 shares for a total of $298,285,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.25M
$76.00
-$171,278,160.00
0
Aug 17
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 15
Form 4
+3.84%
83.33K
$60.00
$4,999,980.00
2.25M
May 21
Form 4
+8.92%
177.78K
$45.00
$7,999,965.00
2.17M
Sep 10
Form 4
∞
1.99M
$18.00
—
1.99M
Apr 22
Form 3
—
0
—
—
0
No matching records found

Principia Biopharma Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.98M
$100.00
-$298,285,500.00
0
Sep 28
Form 4
—
0
—
—
0
Jun 4
Form 4
+13.60%
357.14K
$28.00
$9,999,976.00
2.98M
Oct 18
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Sep 13
Form 4
∞
2.63M
$17.00
—
2.63M
Sep 18
Form 3
—
0
—
—
0
No matching records found

Arcellx, Inc. (ACLX) Snapshot price: $64.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.42%
-1.01M
$45.01
-$45,589,317.35
4.49M
May 11
Form 4
∞
5.5M
$15.00
—
5.5M
Feb 8
Form 3
—
0
—
—
0
No matching records found

Design Therapeutics, Inc. (DSGN) Snapshot price: $2.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
+16.00%
900K
$8.42
$7,574,078.00
6.53M
Dec 16 - Dec 20
Form 4
—
0
—
—
0
Jun 15
Form 4
∞
5.63M
$20.00
—
5.63M
Mar 30
Form 4
—
0
—
—
0
Mar 25
Form 3
—
0
—
—
0
No matching records found

Nkarta, Inc. (NKTX) Snapshot price: $10.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2M
$10.00
$20,000,000.00
2M
Mar 27
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 8
Form 4
∞
1.33M
$15.00
$19,999,995.00
1.33M
Apr 28
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jul 9
Form 3
—
0
—
—
0
No matching records found